Healthcare

Bioprocessing

The healthcare industry is seeing an increased emphasis on emerging therapeutic modalities such as cell and gene therapy. But the ecosystem required to support these sectors is still young and fragmented. 

Working with businesses across this developing sector, we support the growth of cutting-edge companies that are producing and distributing vaccines, therapeutics, antibiotics, diagnostics and more. With extensive experience in biopharma and adjacent areas like pharma services, our investment professionals partner with companies focused on large molecule therapeutics—a growing and vital component of biopharma.

We believe there is substantial opportunity to invest in the large molecule ecosystem to help accelerate the development, manufacturing and distribution of lifesaving therapeutics.

Megan Preiner Megan Preiner Managing Director
From One to Twenty: How CSafe Became a Leader in the Pharma Cold Chain
2023 Healthcare Trends and Our Outlook for 2024

No results were found

No results were found